Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke

A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 306 participants.

Also called NCT07365475

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 306 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07365475
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07365475. Randomized; single masking; primary purpose treatment. Start 2026-01-30 (anticipated); primary completion 2028-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke
Acronym
AMASS2
Condition
Acute Ischemic Stroke From Large Vessel Occlusion
Intervention (Drug)
20% human serum albumin
Lead sponsor
Tianjin Huanhu Hospital (class: other)

Record details

Record id
cardio:ct-nct07365475
Content hash
c16300930d8cb5517ac6ba0c433553d2f55f775e13a04dbae5710885f60d15ae